Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Dec;31(12):1386-1392.
doi: 10.1111/iju.15574. Epub 2024 Sep 10.

Efficacy of a new vacuum erection device (Vigor 2020) for erectile dysfunction: A retrospective study in Japan

Masato Shirai  1 , Masataka Sano  1 , Yuta Anno  1 , Keisuke Ishikawa  1 , Ayumu Taniguchi  1 , Akimasa Kure  1 , Yuka Uesaka  1 , Taiji Nozaki  1 , Shinichiro Fukuhara  2 , Atsushi Iwasa  3 , Kazuhiro Kobayashi  4 , Jun Kato  5 , Akira Tsujimura  1
Affiliations
Observational Study

Efficacy of a new vacuum erection device (Vigor 2020) for erectile dysfunction: A retrospective study in Japan

Masato Shirai et al. Int J Urol. 2024 Dec.

Abstract

Objectives: The vacuum erection device (VED) is a second-line treatment tool recommended in erectile dysfunction (ED) guidelines but has long been unavailable in Japan. A new VED, Vigor 2020® (A & HB Company Limited, Tokyo, Japan), has now been manufactured and received medical approval from the Pharmaceuticals and Medical Devices Agency in Japan. We conducted a retrospective observational study of ED patients who used Vigor 2020 in clinical practice.

Methods: We analyzed male ED patients aged ≥20 years treated with Vigor 2020 in our outpatient clinics. The primary endpoint was improvement of erection as evaluated by an Erection Hardness Score (EHS) of ≥1 point. Secondary endpoints were improvement of sexual function and adverse events as evaluated by the International Index of Erectile Function (IIEF) and Male Sexual Health Questionnaire for assessing ejaculatory dysfunction (MSHQ-EjD).

Results: Thirty-three patients (mean age, 57.21 [27-86] years) could be evaluated before and after using Vigor 2020. Among the 16 patients with baseline EHS ≤2, 14 (93.33%) improved by ≥1 point, and 10 of these 16 patients (62.50%) improved to EHS ≥3 and could insert vaginally. Significant improvement was observed for IIEF total score and for the MSHQ-EjD in patients with an EHS of ≥3 after use of Vigor 2020. No patient experienced significant adverse events.

Conclusions: The Vigor 2020 may be an efficacious treatment tool for ED. Patients with significant ED experienced not only significant improvement of erection but also improvement of ejaculation with its use.

Keywords: Erection Hardness Score; Vigor 2020; ejaculatory dysfunction; erectile dysfunction; vacuum erection device.

PubMed Disclaimer

References

REFERENCES

    1. McCabe MP, Sharlip ID, Atalla E, Balon R, Fisher AD, Laumann E, et al. Definitions of sexual dysfunctions in women and men: a consensus statement from the fourth international consultation on sexual medicine 2015. J Sex Med. 2016;13:135–143.
    1. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM‐7). Eur Urol. 2003;44:637–649.
    1. Sand MS, Fisher W, Rosen R, Heiman J, Eardley I. Erectile dysfunction and constructs of masculinity and quality of life in the multinational Men's Attitudes to Life Events and Sexuality (MALES) study. J Sex Med. 2008;5:583–594.
    1. Tsujimura A, Kiuchi H, Soda T, Takezawa K, Okuda H, Fukuhara S, et al. Sexual life of Japanese patients with erectile dysfunction taking phosphodiesterase type 5 inhibitors: an internet survey using the Psychological and Interpersonal Relationship Scales‐Short Form questionnaire. Int J Urol. 2014;21:821–825.
    1. Hatzimouratidis K, Salonia A, Adaikan G, Buvat J, Carrier S, el‐Meliegy A, et al. Pharmacotherapy for erectile dysfunction: recommendations from the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2016;13:465–488.

Publication types